SCHEMBL22188201

SCHEMBL22188201

CC(C)c1c(-c2ccc(F)cc2)c(=O)c(C(=O)O)cn1C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HMGCR P04035 3/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.37
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
BCL2L1 Q07817 1/20 0.35
BAD Q92934 1/20 0.35
LMNA P02545 1/20 0.34
TOP2A P11388 1/20 0.34
TOP2B Q02880 1/20 0.34
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP7 P09237 1/20 0.33
MMP9 P14780 1/20 0.33
MMP13 P45452 1/20 0.33
NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22188195 0.85 ELANE (0.43) HMGCRPTGDR2NOTUM
SCHEMBL22188215 0.85 KDM4E (0.43) KDM4EALDH1A1TDP1L3MBTL1HMGCR
SCHEMBL22188193 0.82 GRIA2 (0.43) KDM4EALDH1A1TDP1L3MBTL1PTGDR2
SCHEMBL21776525 0.77 SMN1; SMN2 (0.41) KDM4EALDH1A1PTGDR2LMNA
SCHEMBL9751010 0.75 HMGCR (0.49) KDM4EALDH1A1TDP1L3MBTL1HMGCR
SCHEMBL29720900 0.74 TGFBR1 (0.42) TDP1HMGCRPTGDR2ADORA2AADORA1
SCHEMBL29811072 0.74 ELANE (0.43) HMGCRPTGDR2
SCHEMBL9764350 0.73 KDM4E (0.43) KDM4EALDH1A1TDP1L3MBTL1HMGCR
Hydrochloric Acid SCHEMBL29812369 0.73 ELANE (0.42) HMGCRPTGDR2
SCHEMBL23147433 0.72 NOTUM (0.42) KDM4EALDH1A1BCL2L1BADLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020141470-A1 QUINOLINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES ARRAY BIOPHARMA INC. (US) 2020-07-09 WO disclosed
US-20200216416-A1 QUINOLINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES ARRAY BIOPHARMA INC. (US) 2020-07-09 US disclosed
US-20200216416-A1 QUINOLINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES ARRAY BIOPHARMA INC. (US) 2020-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216416-A1 QUINOLINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES RET, MET, MERTK KDM4E 848/4885ALDH1A1 2830/4885TDP1 3208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.